ࡱ> *+ l \pThe Free Software Foundation B=PF0*8X@"1 Helvetica1Courier1 Courier New1 Courier New1 Helvetica$#,##0_);($#,##0)$#,##0_);[Red]($#,##0)$#,##0.00_);($#,##0.00)$#,##0.00_);[Red]($#,##0.00)-**_($* #,##0_);_($* (#,##0);_($* "-"_);_(@_)*)'_(* #,##0_);_(* (#,##0);_(* "-"_);_(@_)5,2_($* #,##0.00_);_($* (#,##0.00);_($* "-"??_);_(@_)2+/_(* #,##0.00_);_(* (#,##0.00);_(* "-"??_);_(@_)2$#,##0.00;[Red]$#,##0.003$#,##0.00;[Red]($#,##0.00)4$#,##0;[Red]($#,##00)50.00%;[Red](0.00%)6 0%;[Red](0%)7#,##0.00;[Red](#,##0.00)8#,##0;[Red](#,##0)                + ) , *   Ј ~~ ؈ ~~#؈ ~~ ؈ ~~7#܈ ~~8#܈ ~~83ffff̙̙3f3fff3f3f33333f33&vEXPLANATORY NOTE The Reporting KEXPLANATORY NOTE The (1) )EXPLANATORY NOTE The (2) W;EXPLANATORY NOTE The (3)&LWarrants Received for Issuance l  4  dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??EXPLANATORY NOTE The (1)EXPLANATORY NOTE The (2)EXPLANATORY NOTE The (3)!Warrants Received for Issuance U } $} $ } $} $ }  4     TherapeuticsMD, Inc.SC 13D/A 04/16/2018jbEXPLANATORY NOTE: The Reporting Person(s) is filing this amendment to correct the aggregate numberCUSIP No. 88338N 10 7Page 2 of 11 Pages    ~ " Name of Reporting Persons.    Robert J. Smith~  0 (Check the Appropriate Box if a Member of (a) ?a Group (b) ?~  SEC Use Only~ Source of FundsPF ? Personal Funds~ 0(Check if Disclosure of Legal Proceedings ?2*is Required Pursuant to Items 2(d) or 2(e)~ ,$Citizenship or Place of Organization United StatesNumber of Shares~ Sole Voting PowerBeneficially Owned~ R^by Each Reporting~ "Shared Voting Power Person With -0-~ &Sole Dispositive Power~ R^~ * Shared Dispositive PowerDPl<0$gO(sJ2j,p& !"#$%&'()*+,-./0123    -0-~ !..!&Aggregate Amount Beneficially Owned by""Each Reporting Person#~ #R^~ $21$)Check if the Aggregate Amount in Row (11)%%Excludes Certain Shares& &?~ '6.'&Percent of Class Represented by Amount(( of Row (11)))* *4.56%~ +: +Type of Reporting Person,,- -IN...../0$1____________________________12)Created by Morningstar Document Research.03(http://documentresearch.morningstar.com/,|`F{X@#wkC=PF0*8X> @:'332211--++**((''&&%%$$##""!!     l  7a"/(  dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??!EXPLANATORY NOTE The Reporting EXPLANATORY NOTE The (2)EXPLANATORY NOTE The (3)!Warrants Received for Issuance U } $} $ } $} $ }  7     TherapeuticsMD, Inc.SC 13D/A 04/16/2018jbEXPLANATORY NOTE: The Reporting Person(s) is filing this amendment to correct the aggregate numberCUSIP No. 88338N 10 7Page 3 of 11 Pages    ~ " Name of Reporting Persons.   3 +Energy Capital, LLC, an entity solely owned  by Robert J. Smith~  0(Check the Appropriate Box if a Member of (a) ?a Group (b) ?~  SEC Use Only~ Source of FundsPF ? Personal Funds~ 0(Check if Disclosure of Legal Proceedings ?2*is Required Pursuant to Items 2(d) or 2(e)~ ,$Citizenship or Place of Organization United StatesNumber of Shares~ Sole Voting PowerBeneficially Owned~  2by Each Reporting~ "Shared Voting Power Person With -0-~ &Sole Dispositive PowerD2l<0$gO _G! N> !"#$%&'()*+,-./0123456   ~  2!!~ !* !Shared Dispositive Power""" "-0-~ #..#&Aggregate Amount Beneficially Owned by$$Each Reporting Person%%&~ & 2~ '21')Check if the Aggregate Amount in Row (11)((Excludes Certain Shares) )?~ *6.*&Percent of Class Represented by Amount++ of Row (11),,- -0.38%~ .: .Type of Reporting Person//0 0OO1111123$4____________________________15)Created by Morningstar Document Research.06(http://documentresearch.morningstar.com/2Qo@']E+=PF0*8X> @B(66554400..--++**))((''&&$$##""!!     l  649  dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??!EXPLANATORY NOTE The Reporting EXPLANATORY NOTE The (1)EXPLANATORY NOTE The (3)!Warrants Received for Issuance U } $} $ } $} $ }  6     TherapeuticsMD, Inc.SC 13D/A 04/16/2018jbEXPLANATORY NOTE: The Reporting Person(s) is filing this amendment to correct the aggregate numberCUSIP No. 88338N 10 7Page 4 of 11 Pages    ~ " Name of Reporting Persons.   1 )Plato & Associates, LLC, an entity solely  owned by Robert J. Smith~  0(Check the Appropriate Box if a Member of (a) ?a Group (b) ?~  SEC Use Only~ Source of FundsPF ? Personal Funds~ 0(Check if Disclosure of Legal Proceedings ?2*is Required Pursuant to Items 2(d) or 2(e)~ ,$Citizenship or Place of Organization United StatesNumber of Shares~ Sole Voting PowerBeneficially Owned~ by Each Reporting~ "Shared Voting Power Person With -0-~ &Sole Dispositive Power~ DPl<0$gO[5bR !"#$%&'()*+,-./012345  ~ * Shared Dispositive Power!!! !-0-~ ".."&Aggregate Amount Beneficially Owned by##Each Reporting Person$$%~ %~ &21&)Check if the Aggregate Amount in Row (11)''Excludes Certain Shares( (?~ )6.)&Percent of Class Represented by Amount** of Row (11)++, ,3.54%~ -: -Type of Reporting Person../ /OO0000012$3____________________________14)Created by Morningstar Document Research.05(http://documentresearch.morningstar.com/0@CrYw]! =PF0*8X> @B(554433//--,,**))((''&&%%##""!!     l  5EJ  dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??!EXPLANATORY NOTE The Reporting EXPLANATORY NOTE The (1)EXPLANATORY NOTE The (2)!Warrants Received for Issuance U } $} $ } $} $ }  5     TherapeuticsMD, Inc.SC 13D/A 04/16/2018jbEXPLANATORY NOTE: The Reporting Person(s) is filing this amendment to correct the aggregate numberCUSIP No. 88338N 10 7Page 5 of 11 Pages    ~ " Name of Reporting Persons.   5 -Jo Cee, LLC, an entity solely owned by Robert  J. Smith~  0(Check the Appropriate Box if a Member of (a) ?a Group (b) ?~  SEC Use Only~ Source of FundsPF ? Personal Funds~ 0(Check if Disclosure of Legal Proceedings ?2*is Required Pursuant to Items 2(d) or 2(e)~ ,$Citizenship or Place of Organization United StatesNumber of Shares~ Sole Voting PowerBeneficially Owned~ _9by Each Reporting~ "Shared Voting Power Person With -0-~ &Sole Dispositive Power~ _9DDl<0$gO gA)n ^& !"#$%&'()*+,-./01234  ~ * Shared Dispositive Power!!! !-0-~ ".."&Aggregate Amount Beneficially Owned by##Each Reporting Person$~ $_9~ %21%)Check if the Aggregate Amount in Row (11)&&Excludes Certain Shares' '?~ (6.(&Percent of Class Represented by Amount)) of Row (11)**+ +0.43%~ ,: ,Type of Reporting Person--. .OO/////01$2____________________________13)Created by Morningstar Document Research.04(http://documentresearch.morningstar.com/.Cq1u9-!=PF0*8X> @B(443322..,,++))((''&&%%$$##""!!     l  iS  dMbP?_*+%,&٭e2?'٭e2?(٭e2?)٭e2?",D/??!EXPLANATORY NOTE The Reporting EXPLANATORY NOTE The (1)EXPLANATORY NOTE The (2)EXPLANATORY NOTE The (3)U } } } 2      TherapeuticsMD, Inc.SC 13D/A 04/16/20185-Warrants Received for Issuance of Credit Line Exhibit No.Date of DocumentDescription of Document~ * 06/19/12# Note Purchase Agreement (1) 333333$@ 06/19/12 Security Agreement (1) ffffff$@ 06/19/12, $Secured Promissory Note, form of (1) $@ 06/19/122 *Common Stock Purchase Warrant, form of (1) $@ 09/26/12) !Securities Purchase Agreement (2)%@01/31/13Revolving Line Note (3)$____________________________1)Created by Morningstar Document Research.0(http://documentresearch.morningstar.com/,!|qeYMfa =PF0*8X> @ Root Entry FBook  S  !"#$%&'()